This event outlined the various coverage-related elements at play over the next six to nine months, their tradeoffs, and how they may impact various stakeholders, including consumers, state leaders, and payers.
This event helped the audience understand the current policy landscape shaping Medicare and Medicaid programs as well as principles of person- and community-centered care. Speakers discussed lessons learned from the PHE, including insights from recent research and on-the-ground experts, and highlighted policy levers available to state and federal policymakers to build upon these current flexibilities.
Voices from the Frontlines brought together leading voices in health care and public health for an afternoon of conversation and inspiration. For the first time, these exceptional individuals, who have been paramount in the effort to combat COVID-19 over the past 18 months, were together on one virtual stage. This event allowed our community the opportunity to directly engage with those on the frontlines of this pandemic, and to hear their personal stories of perseverance in the face of great challenge.
During this exclusive on-the-record briefing for reporters, Admiral Rachel L. Levine, M.D., Assistant Secretary for Health at the U.S. Department of Health and Human Services, provided some opening remarks and responded to audience questions.
This briefing provided a primer on health data, how we use it, and how we process it. Attendees learned the challenges of leveraging health data for decision-making and the implications for providers, payers, and patients during the COVID-19 pandemic.
This briefing will explore how the U.S. has fared during the COVID-19 pandemic to-date and highlight key takeaways learned in the U.S. response, as well as important lessons learned from peer countries.
In this briefing, experts discussed how flu and the COVID-19 pandemic have intersected over the past 18 months and why we should also prioritize flu preparedness policy. Panelists also highlighted available federal policy levers and discuss policy strategies to improve our flu response.
The Health Equity Summit, a program of the Alliance for Health Policy’s 2021 Signature Series, reflected upon lessons learned and look at policies and practices that perpetuate existing inequities in our society. Exploring a multitude of factors both current and historical, this Summit addressed the tradeoffs between inaction and intervention, as well as tangible policy options to start advancing health equity now.
There is no excerpt because this is a protected post.
This briefing discussed the results of the latest African American Research Collaborative (AARC) survey regarding COVID-19 vaccines, their importance, and explored potential strategies to increase vaccination rates, particularly ones tailored to different populations.
There is no excerpt because this is a protected post.
Expert panelists delved into where America stands in public health a year into the COVID-19 pandemic. They discussed how the COVID-19 pandemic has shaped clinical care, state preparedness, and the individual consumer experience and shed light on promising frameworks and infrastructures being built today to protect Americans from a major public health emergency tomorrow.
Attendees learned the challenges and opportunities states face in safe and timely vaccine deployment and supply management, plans states are executing to ensure equitable vaccine distribution, and plans states are executing to ensure equitable vaccine distribution along the way.
This briefing explored the current state of COVID-19 vaccine deployment efforts, cultural, historical, and political influences that may generate feelings of hesitancy, and how to ensure optimal vaccine uptake in key populations.
Dr. Stephen Hahn addressed the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.
This briefing explored how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists also illustrated the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.
This discussion focused on measures industry stakeholders have taken for safe COVID-19 vaccine deployment and the immediate steps these stakeholders will take in the first 48 hours after the Emergency Use Authorization was approved.
Sessions on Day 2 of the Post Election Symposium included a fireside chat with futurist Ian Morrison and leaders from the ground discussed the long-term vision for rebuilding the health system.
Sessions on Day 1 of the Post Election Symposium provided an analysis of the election results and potential impacts for health care and a discussion on the gaps in our health care system that COVID-19 exposed.
November 16-17 | This virtual symposium will gather a range of experts after election day to discuss how the results could influence the health policy agenda in 2021 and beyond.
This briefing will overview the complex ecosystem of federal, state, and private programs that coexist to integrate medical, LTSS, and social services for low-income seniors.
Day 3 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will address how we collect and operationalize patient feedback to create patient-centered care at a systems level.
Day 2 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will explore successful mechanisms to support patients navigate the current, highly complex health care system and foster independence in decision making.
Day 1 of our Voice of the Patient Summit, a program of the 2020 Signature Series, includes an opening keynote presentation and panel focusing on strategies for effective communication and shared decision making from the patient and caregiver perspectives.
The COVID-19 pandemic has exposed both new and longstanding needs of long-term care patients. Experts will overview the recent changes, remaining gaps, and benefits and risks to long-term care patients, caregivers, providers, and payers.
This is the final event in Part I of our Signature Series focusing on disruptors and transformers in health care. This briefing explored the manufacturing, distribution, delivery, and coverage approaches that will enable nationwide COVID-19 vaccine uptake.
Dr. Anand Shah provided opening remarks and answered questions about the U.S. Food and Drug Administration’s role in the national COVID-19 response.
This solutions-focused discussion explored policy interventions at the federal, state, and local levels to advance mental health during the ongoing pandemic.
During this on-the-record briefing for reporters, Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Disease at the National Institutes of Health provided insight into the status of the COVID-19 pandemic. Dr. Fauci discussed the status of spread of the virus in the United States and highlighted progress toward successful treatments and vaccines.
This webinar will address the specific threats posed by COVID-19 to children in the short- and long-term and provide policy options that may support children’s physical and mental health.